Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory pathway that could trigger a seismic shift in how bespoke gene editing therapies ...

Wheat feeds billions, so even small gains matter a great deal. It is also vast in scope, covering more than 215 million hectares each year, according to a recent study. A new resource maps which wheat ...

An international scientific team says gene editing technologies can be repurposed to provide a transformative solution for restoring genetic diversity and saving endangered species. In an article ...

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders ...

Abstract: Rheumatoid Arthritis (RA)is a chronic autoimmune disorder. Genetic factors and signalling pathways influence its progression. This study integrates pathway-based gene prioritization and ...

Specialized metabolites (also called natural products or secondary metabolites) derived from bacteria, fungi, marine organisms and plants constitute an important source of antibiotics, anti-cancer ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Large-scale comparison of gene families across ...

In an interview with former Fox News journalist Megyn Kelly, FDA Commissioner Marty Makary introduced a new mechanism-driven pathway that could be leveraged by rare disease therapies while saying that ...

On the left, identified organically bounded C-14 (OBC-14, red dots) in metabolites of zebrafish brain were labeled in the KEGG global pathway map. The blending of C-14 induced significant effects such ...